What are the appropriate IV doses of Benadryl (diphenhydramine), Famotidine, and Solu-Medrol (methylprednisolone) for a 28kg, 5-year-old child presenting with an allergic reaction characterized by hives and facial swelling?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Appropriate IV Medication Dosing for a 28kg Child with Allergic Reaction

Critical Safety Consideration First

While you plan to administer adjunctive medications, this presentation of hives with facial swelling warrants serious consideration for IM epinephrine, as facial swelling may represent angioedema and potential airway involvement—a criterion for anaphylaxis treatment. 1

Specific Dosing for This 28kg Child

Diphenhydramine (Benadryl) IV

  • Dose: 28-56 mg IV (1-2 mg/kg per dose) 1
  • Maximum: 50 mg per dose 1, 2
  • For this 28kg child: Give 28 mg IV (using the lower end of the range) to stay well below the 50 mg maximum 1
  • Critical safety warning: Administer slowly over several minutes, NOT as rapid IV push 3, 4
    • Rapid IV administration has been associated with cardiac arrest in pediatric patients, even at therapeutic doses 3
    • Cardiovascular effects including hypotension and arrhythmias are more common with IV route 3, 4

Famotidine (H2-Blocker) IV

  • Dose: 7 mg IV (0.25 mg/kg) 5
  • Maximum: 40 mg/day 5
  • Administration: Inject over at least 2 minutes OR as a 15-minute infusion 5
  • Frequency: Every 12 hours 5
  • Note: The guidelines reference ranitidine (1 mg/kg), but since famotidine is now the standard H2-blocker, use 0.25 mg/kg per FDA labeling 1, 5

Methylprednisolone (Solu-Medrol) IV

  • Dose: 28 mg IV (1 mg/kg) 1
  • Maximum: 60-80 mg 1
  • Administration: Can be given IV push over several minutes or as infusion 6
  • The guideline range is 1-2 mg/kg/day, but 1 mg/kg is standard for acute allergic reactions 1

Clinical Algorithm for Decision-Making

Reassess for Anaphylaxis Criteria Before Proceeding

You must evaluate for any of the following, which would mandate IM epinephrine FIRST: 1

  • Respiratory involvement: wheezing, stridor, dyspnea, hypoxemia
  • Cardiovascular involvement: hypotension, tachycardia, dizziness, syncope
  • Persistent gastrointestinal symptoms: vomiting, cramping abdominal pain
  • Rapidly progressive symptoms

If ANY of these are present, give IM epinephrine 0.3 mg (0.01 mg/kg) in the anterolateral thigh IMMEDIATELY before adjunctive medications 1

If Truly Isolated Cutaneous Reaction

  • Proceed with the adjunctive medication regimen outlined above 1
  • The combination of H1-antihistamine (diphenhydramine) plus H2-antihistamine (famotidine) is superior to H1-antihistamine alone for urticaria control 1
  • Corticosteroids may help prevent biphasic reactions, though their acute benefit is limited 1

Critical Pitfalls to Avoid

Diphenhydramine Administration Errors

  • Never give diphenhydramine as rapid IV push 3, 4
  • Consider using oral liquid formulation instead of IV when possible, as it absorbs rapidly and avoids cardiovascular risks 1, 2
  • Be aware that sedation may mask progression of symptoms 2, 4

Underestimating Severity

  • Facial swelling can progress to airway compromise 1
  • Have IM epinephrine immediately available at bedside 1
  • Monitor continuously for at least 4-6 hours for biphasic reactions 1

Observation Period

  • Observe for minimum 4-6 hours after symptom resolution 1
  • Biphasic reactions occur in a subset of patients and can be severe 1
  • Longer observation warranted if symptoms were severe or required multiple interventions 1

Discharge Planning (If Applicable)

  • Prescribe epinephrine auto-injector (0.3 mg for >25 kg) 1
  • Continue oral antihistamines for 2-3 days 1
  • Consider oral prednisone 1 mg/kg daily for 2-3 days 1
  • Arrange allergy/immunology follow-up 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pediatric Diphenhydramine Dosing for Allergic Reactions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cardiac Arrest Following the Administration of Intravenous Diphenhydramine for Sedation to an Infant With Congenital Heart Disease.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2021

Research

Diphenhydramine: A Review of Its Clinical Applications and Potential Adverse Effect Profile.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.